Cargando…
Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis
OBJECTIVE: Most comprehensive treatments for PBC include UDCA, combination of methotrexate (MTX), corticosteroids (COT), colchicine (COC) or bezafibrate (BEF), cyclosporin A (CYP), D-penicillamine (DPM), methotrexate (MTX), or azathioprine (AZP). Since the optimum treatment regimen remains inconclus...
Autores principales: | Zhu, Gui-Qi, Huang, Sha, Huang, Gui-Qian, Wang, Li-Ren, Lin, Yi-Qian, Wu, Yi-Ming, Shi, Ke-Qing, Wang, Jiang-Tao, Zhou, Zhi-Rui, Braddock, Martin, Chen, Yong-Ping, Zhou, Meng-Tao, Zheng, Ming-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695204/ https://www.ncbi.nlm.nih.gov/pubmed/26109432 |
Ejemplares similares
-
Network Meta-Analysis of Randomized Controlled Trials: Efficacy and Safety of UDCA-Based Therapies in Primary Biliary Cirrhosis
por: Zhu, Gui-Qi, et al.
Publicado: (2015) -
A network meta-analysis of the efficacy and side effects of udca-based therapies for primary sclerosing cholangitis
por: Zhu, Gui-Qi, et al.
Publicado: (2015) -
Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection
por: Huang, Gui-Qian, et al.
Publicado: (2015) -
Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver Resection
por: Huang, Sha, et al.
Publicado: (2015) -
Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis
por: Zhu, Gui-Qi, et al.
Publicado: (2015)